ProTransit is commercializing Pro-MP™ a patented, sustained-release microparticle A drug delivery platform that penetrates the skin to deliver a wide range of pharmaceutical actives potentially better, faster, and safer than needles and pills. Pro-MP™ microparticles releasing superoxide dismutase (SOD) and catalase (CAT) antioxidants. Diameter: approximately 200 billionths of a meter. Particle release: up to 192 hours Based on 10+ years of research at the University of Nebraska Medical Center, Creighton University School of Medicine and USC Keck School of Medicine, ProTransit has developed Pro-MP™, a unique, patented, sustained-release microparticle drug delivery technology shown to penetrate the skin, scalp, eye, and mucosal tissues to deliver active ingredients. Pro-MP may also be IV-administered. R&D continues to explore exciting new formulations with Pro-MP that deliver ingredients to treat diseases with unmet needs for better clinical outcomes. Using Pro-MP, a unique and effective ingredient delivery technology to: - Penetrate the skin and slowly release pharmaceutical active ingredients locally for up to 192 hours, with minimal systemic uptake - Deliver powerful antioxidants into the skin 24/7 to neutralize free radicals and optimize skin health and appearance - Target the hair follicle directly to stimulate hair regrowth and improve hair quality
